About PreludeDx
PreludeDx delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.
Leadership at PreludeDx
The team at the top of the org chart.
DF
Daniel Forche
President and CEO
48 reports
AW
Andrew Wade
CFO
2 reports
TB
Troy Bremer
Chief Scientific Officer
14 reports
AS
Andrew Sundberg
VP, Global Sales
13 reports
CE
Chris Emery
Vice President Strategic Marketing And Business Development
3 reports
AC
Alyssa Gavegan Canavan
Regional Sales Director
MT
Matthew Tate
VP, Business Development
JN
Joseph Nollar
Vice President Of Technology
1 report
MR
Mimi Reyes
SVP, Operations
6 reports
Board
OB
Olav Bergheim
Chairman
AS
Alejandro Sanchez
Board Member
DM
Derek J. Maetzold
Board Member
GA
Gerrit Adams
Board Member
Open Jobs at PreludeDx (9)
Sort